Interleukin-2: From T Cell Growth and Homeostasis to Immune Reconstitution of HIV Patients

Vitamins and Hormones

Volumn 74, Issue , 2006, Pages 531-547

  Kryworuchko, Marko ^a   Thèze, Jacques ^b  

^a CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^b INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2;

ANIMAL; HOMEOSTASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; PHYSIOLOGY; REVIEW; T LYMPHOCYTE;

ANIMALS; HIV INFECTIONS; HOMEOSTASIS; HUMANS; INTERLEUKIN-2; T-LYMPHOCYTES;

EID: 33947719768     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0083-6729(06)74021-3     Document Type: Review

References (80)

1. Aandahl E.M., Michaelsson J., Moretto W.J., Hecht F.M., and Nixon D.F. Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. J. Virol. 78 (2004) 2454-2459
2. Abdkader K., Al-Hetheel A., Sant N., Angel J.B., Kumar A., Diaz-Mitoma F., and Kryworuchko M. Disruption of cytokine signaling in T cells from HIV+ pateints: Role in pathogenesis. Ontario HIV Treatment Network Research Conference, Toronto, Ontario, Canada (2005)
3. Almeida A.R., Legrand N., Papiernik M., and Freitas A.A. Homeostasis of peripheral CD4+ T cells: IL-2R alpha and IL-2 shape a population of regulatory cells that controls CD4+ T cell numbers. J. Immunol. 169 (2002) 4850-4860
4. Assier E., Jullien V., Lefort J., Moreau J.L., Di Santo J.P., Vargaftig B.B., Lapa e Silva J.R., and Theze J. NK cells and polymorphonuclear neutrophils are both critical for IL-2-induced pulmonary vascular leak syndrome. J. Immunol. 172 (2004) 7661-7668
5. Assier E., Jullien V., Lefort J., Moreau J.L., Vargaftig B.B., Lapa e Silva J.R., and Theze J. Constitutive expression of IL-2Rbeta chain and its effects on IL-2-induced vascular leak syndrome. Cytokine 32 (2005) 280-286
6. Atkins M.B. Interleukin-2: Clinical applications. Semin. Oncol. 29 (2002) 12-17
7. Bani L., Kryworuchko M., Pasquier V., Salamero J., and Thèze J. Unstimulated human CD4 lymphocytes express a cytoplasmic immature form of the common cytokine receptor gamma-chain. J. Immunol. 167 (2001) 344-349
8. Benveniste E.N., and Merrill J.E. Stimulation of oligodendroglial proliferation and maturation by interleukin-2. Nature 321 (1986) 610-613
9. Chastagner P., Reddy J., and Theze J. Lymphoadenopathy in IL-2-deficient mice: Further characterization and overexpression of the antiapoptotic molecule cellular FLIP. J. Immunol. 169 (2002) 3644-3651
10. Cheng L.E., Ohlen C., Nelson B.H., and Greenberg P.D. Enhanced signaling through the IL-2 receptor in CD8+ T cells regulated by antigen recognition results in preferential proliferation and expansion of responding CD8+ T cells rather than promotion of cell death. Proc. Natl. Acad. Sci. USA 99 (2002) 3001-3006
11. Chopra R.K., Raj N.B., Scally J.P., Donnenberg A.D., Adler W.H., Saah A.J., and Margolick J.B. Relationship between IL-2 receptor expression and proliferative responses in lymphocytes from HIV-1 seropositive homosexual men. Clin. Exp. Immunol. 91 (1993) 18-24
12. Davey Jr. R.T., Murphy R.L., Graziano F.M., Boswell S.L., Pavia A.T., Cancio M., Nadler J.P., Chaitt D.G., Dewar R.L., Sahner D.K., Duliege A.M., Capra W.B., et al. Immunologic and virologic effects of subcutaneous interleukin 2 in combination with antiretroviral therapy: A randomized controlled trial. J. Am. Med. Assoc. 284 (2000) 183-189
13. David D., Bani L., Moreau J.L., Demaison C., Sun K., Salvucci O., Nakarai T., de Montalembert M., Chouaib S., Joussemet M., Ritz J., and Theze J. Further analysis of interleukin-2 receptor subunit expression on the different human peripheral blood mononuclear cell subsets. Blood 91 (1998) 165-172
14. David D., Bani L., Moreau J.L., Treilhou M.P., Nakarai T., Joussemet M., Ritz J., Dupont B., Pialoux G., and Thèze J. Regulatory dysfunction of the interleukin-2 receptor during HIV infection and the impact of triple combination therapy. Proc. Natl. Acad. Sci. USA 95 (1998) 11348-11353
15. David D., Nait-Ighil L., Dupont B., Maral J., Gachot B., and Theze J. Rapid effect of interleukin-2 therapy in human immunodeficiency virus-infected patients whose CD4 cell counts increase only slightly in response to combined antiretroviral treatment. J. Infect. Dis. 183 (2001) 730-735
16. David D., Keller H., Nait-Ighil L., Treilhou M.P., Joussemet M., Dupont B., Gachot B., Maral J., and Theze J. Involvement of Bcl-2 and IL-2R in HIV-positive patients whose CD4 cell counts fail to increase rapidly with highly active antiretroviral therapy. AIDS 16 (2002) 1093-1101
17. D'Cruz L.M., and Klein L. Development and function of agonist-induced CD25+ Foxp3+ regulatory T cells in the absence of interleukin 2 signaling. Nat. Immunol. 6 (2005) 1152-1159
18. Devos R., Plaetinck G., Cheroutre H., Simons G., Degrave W., Tavernier J., Remaut E., and Fiers W. Molecular cloning of human interleukin 2 cDNA and its expression in E. coli. Nucleic Acids Res. 11 (1983) 4307-4323
19. Dong C., Davis R.J., and Flavell R.A. MAP kinases in the immune response. Annu. Rev. Immunol. 20 (2002) 55-72
20. D'Souza W.N., Schluns K.S., Masopust D., and Lefrancois L. Essential role for IL-2 in the regulation of antiviral extralymphoid CD8 T cell responses. J. Immunol. 168 (2002) 5566-5572
21. Eckenberg R., Rose T., Moreau J.L., Weil R., Gesbert F., Dubois S., Tello D., Bossus M., Gras H., Tartar A., Bertoglio J., Chouaib S., et al. The first alpha helix of interleukin (IL)-2 folds as a homotetramer, acts as an agonist of the IL-2 receptor beta chain, and induces lymphokine-activated killer cells. J. Exp. Med. 191 (2000) 529-540
22. Ellery J.M., and Nicholls P.J. Alternate signalling pathways from the interleukin-2 receptor. Cytokine Growth Factor Rev. 13 (2002) 27-40
23. Espinoza-Delgado I., Bosco M.C., Musso T., Gusella G.L., Longo D.L., and Varesio L. Interleukin-2 and human monocyte activation. J. Leukoc. Biol. 57 (1995) 13-19
24. Fontenot J.D., Rasmussen J.P., Gavin M.A., and Rudensky A.Y. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 6 (2005) 1142-1151
25. Frauwirth K.A., and Thompson C.B. Regulation of T lymphocyte metabolism. J. Immunol. 172 (2004) 4661-4665
26. Fujii H., Ogasawara K., Otsuka H., Suzuki M., Yamamura K., Yokochi T., Miyazaki T., Suzuki H., Mak T.W., Taki S., and Taniguchi T. Functional dissection of the cytoplasmic subregions of the IL-2 receptor betac chain in primary lymphocyte populations. EMBO J. 17 (1998) 6551-6557
27. Gaffen S.L., Wang S., and Koshland M.E. Expression of the immunoglobulin J chain in a murine B lymphoma is driven by autocrine production of interleukin 2. Cytokine 8 (1996) 513-524
28. Gesbert F., Delespine-Carmagnat M., and Bertoglio J. Recent advances in the understanding of interleukin-2 signal transduction. J. Clin. Immunol. 18 (1998) 307-320
29. Gesbert F., Moreau J.L., and Theze J. IL-2 responsiveness of CD4 and CD8 lymphocytes: Further investigations with human IL-2Rbeta transgenic mice. Int. Immunol. 17 (2005) 1093-1102
30. Gillis S., Ferm M.M., Ou W., and Smith K.A. T cell growth factor: Parameters of production and a quantitative microassay for activity. J Immunol. 120 (1978) 2027-2032
31. Gonzalez-Garcia A., Merida I., Martinez A.C., and Carrera A.C. Intermediate affinity interleukin-2 receptor mediates survival via a phosphatidylinositol 3-kinase-dependent pathway. J. Biol. Chem. 272 (1997) 10220-10226
32. Granucci F., Vizzardelli C., Pavelka N., Feau S., Persico M., Virzi E., Rescigno M., Moro G., and Ricciardi-Castagnoli P. Inducible IL-2 production by dendritic cells revealed by global gene expression analysis. Nat. Immunol. 2 (2001) 882-888
33. Granucci F., Andrews D.M., Degli-Esposti M.A., and Ricciardi-Castagnoli P. IL-2 mediates adjuvant effect of dendritic cells. Trends Immunol. 23 (2002) 169-171
34. Hauser G.J., Bino T., Rosenberg H., Zakuth V., Geller E., and Spirer Z. Interleukin-2 production and response to exogenous interleukin-2 in a patient with the acquired immune deficiency syndrome (AIDS). Clin. Exp. Immunol. 56 (1984) 14-17
35. Khoruts A., Mondino A., Pape K.A., Reiner S.L., and Jenkins M.K. A natural immunological adjuvant enhances T cell clonal expansion through a CD28-dependent, interleukin (IL)-2-independent mechanism. J. Exp. Med. 187 (1998) 225-236
36. Kinter A.L., Hennessey M., Bell A., Kern S., Lin Y., Daucher M., Planta M., McGlaughlin M., Jackson R., Ziegler S.F., and Fauci A.S. CD25(+)CD4(+) regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4(+) and CD8(+) HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status. J. Exp. Med. 200 (2004) 331-343
37. Kneitz B., Herrmann T., Yonehara S., and Schimpl A. Normal clonal expansion but impaired Fas-mediated cell death and anergy induction in interleukin-2-deficient mice. Eur. J. Immunol. 25 (1995) 2572-2577
38. Kovacs J.A., Vogel S., Albert J.M., Falloon J., Davey Jr. R.T., Walker R.E., Polis M.A., Spooner K., Metcalf J.A., Baseler M., Fyfe G., and Lane H.C. Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus. N. Engl. J. Med. 335 (1996) 1350-1356
39. Koyasu S. The role of PI3K in immune cells. Nat. Immunol. 4 (2003) 313-319
40. Kryworuchko M., Pasquier V., and Theze J. Human immunodeficiency virus-1 envelope glycoproteins and anti-CD4 antibodies inhibit Interleukin-2-induced Jak/STAT signaling in human CD4 T lymphocytes. Clin. Exp. Immunol. 131 (2003) 422-427
41. Kryworuchko M., Abdkader K., Alhetheel A., Sant N., Pasquier V., Kumar A., Diaz-Mitoma F., Keller H., David D., Goujard C., Gilquin J., Viard J.-P., et al. In: Fenton M.J. (Ed). "Fifth Joint Meeting of ICS and ISICR" (2004), Medimond, San Juan, Puerto Rico
42. Kryworuchko M., Pasquier V., Keller H., David D., Goujard C., Gilquin J., Viard J.P., Joussemet M., Delfraissy J.-F., and Thèze J. Defective IL-2-dependent STAT5 signaling in the CD8 T lymphocytes from HIV+ patients: Restoration by HAART. AIDS 18 (2004) 421-426
43. Lenardo M., Chan K.M., Hornung F., McFarland H., Siegel R., Wang J., and Zheng L. Mature T lymphocyte apoptosis: Immune regulation in a dynamic and unpredictable antigenic environment. Annu. Rev. Immunol. 17 (1999) 221-253
44. Lenardo M.J. Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. Nature 353 (1991) 858-861
45. Lentsch A.B., Miller F.N., and Edwards M.J. Mechanisms of leukocyte-mediated tissue injury induced by interleukin-2. Cancer Immunol. Immunother. 47 (1999) 243-248
46. Leonard W.J., and O'Shea J.J. Jaks and STATs: Biological implications. Annu. Rev. Immunol. 16 (1998) 293-322
47. Leung D.T., Morefield S., and Willerford D.M. Regulation of lymphoid homeostasis by IL-2 receptor signals in vivo. J. Immunol. 164 (2000) 3527-3534
48. Lin J.X., and Leonard W.J. The role of Stat5a and Stat5b in signaling by IL-2 family cytokines. Oncogene 19 (2000) 2566-2576
49. Locker G.J., Kapiotis S., Veitl M., Mader R.M., Stoiser B., Kofler J., Sieder A.E., Rainer H., Steger G.G., Mannhalter C., and Wagner O.F. Activation of endothelium by immunotherapy with interleukin-2 in patients with malignant disorders. Br. J. Haematol. 105 (1999) 912-919
50. Malek T.R., and Bayer A.L. Tolerance, not immunity, crucially depends on IL-2. Nat. Rev. Immunol. 4 (2004) 665-674
51. Malek T.R., Porter B.O., Codias E.K., Scibelli P., and Yu A. Normal lymphoid homeostasis and lack of lethal autoimmunity in mice containing mature T cells with severely impaired IL-2 receptors. J. Immunol. 164 (2000) 2905-2914
52. Malek T.R., Yu A., Vincek V., Scibelli P., and Kong L. CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2. Immunity 17 (2002) 167-178
53. Marchetti G., Franzetti F., and Gori A. Partial immune reconstitution following highly active antiretroviral therapy: Can adjuvant interleukin-2 fill the gap?. J. Antimicrob. Chemother. 55 (2005) 401-409
54. McCune J.M. The dynamics of CD4+ T-cell depletion in HIV disease. Nature 410 (2001) 974-979
55. Minami Y., Kono T., Miyazaki T., and Taniguchi T. The IL-2 receptor complex: Its structure, function, and target genes. Annu. Rev. Immunol. 11 (1993) 245-268
56. Miyazaki T., Liu Z.J., Kawahara A., Minami Y., Yamada K., Tsujimoto Y., Barsoumian E.L., Permutter R.M., and Taniguchi T. Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and lck cooperate in hematopoietic cell proliferation. Cell 81 (1995) 223-231
57. Natarajan V., Lempicki R.A., Sereti I., Badralmaa Y., Adelsberger J.W., Metcalf J.A., Prieto D.A., Stevens R., Baseler M.W., Kovacs J.A., and Lane H.C. Increased peripheral expansion of naive CD4+ T cells in vivo after IL-2 treatment of patients with HIV infection. Proc. Natl. Acad. Sci. USA 99 (2002) 10712-10717
58. Nelson B.H. IL-2, regulatory T cells, and tolerance. J. Immunol. 172 (2004) 3983-3988
59. Pau A.K., and Tavel J.A. Therapeutic use of interleukin-2 in HIV-infected patients. Curr. Opin. Pharmacol. 2 (2002) 433-439
60. Poli G. Cytokines and chemokines in HIV infection. In: Pantaleo, G., and Walker B.D. (Eds). "Retroviral Immunology" (2001), Humana Press, Totowa, New Jersey 53-78
61. Rathmell J.C., Vander Heiden M.G., Harris M.H., Frauwirth K.A., and Thompson C.B. In the absence of extrinsic signals, nutrient utilization by lymphocytes is insufficient to maintain either cell size or viability. Mol. Cell 6 (2000) 683-692
62. Sahraoui Y., Ammar A., Lunardi-Iskandar Y., Tsapis A., Spanakis E., N'Go N., Allouche M., Bellile V.G., Jasmin C., and Georgoulias V. Abnormal expression of IL-2R beta (p70)-binding polypeptide on HIV-infected patients' cells. Cell Immunol. 139 (1992) 318-332
63. Sereti I., Martinez-Wilson H., Metcalf J.A., Baseler M.W., Hallahan C.W., Hahn B., Hengel R.L., Davey R.T., Kovacs J.A., and Lane H.C. Long-term effects of intermittent interleukin 2 therapy in patients with HIV infection: Characterization of a novel subset of CD4(+)/CD25(+) T cells. Blood 100 (2002) 2159-2167
64. Sereti I., Anthony K.B., Martinez-Wilson H., Lempicki R., Adelsberger J., Metcalf J.A., Hallahan C.W., Follmann D., Davey R.T., Kovacs J.A., and Lane H.C. IL-2-induced CD4+ T-cell expansion in HIV-infected patients is associated with long-term decreases in T-cell proliferation. Blood 104 (2004) 775-780
65. Sharfe N., Dadi H.K., Shahar M., and Roifman C.M. Human immune disorder arising from mutation of the alpha chain of the interleukin-2 receptor. Proc. Natl. Acad. Sci. USA 94 (1997) 3168-3171
66. Sugamura K., Asao H., Kondo M., Tanaka N., Ishii N., Ohbo K., Nakamura M., and Takeshita T. The interleukin-2 receptor gamma chain: Its role in the multiple cytokine receptor complexes and T cell development in XSCID. Annu. Rev. Immunol. 14 (1996) 179-205
67. Suzuki H., Hayakawa A., Bouchard D., Nakashima I., and Mak T.W. Normal thymic selection, superantigen-induced deletion and Fas-mediated apoptosis of T cells in IL-2 receptor beta chain-deficient mice. Int. Immunol. 9 (1997) 1367-1374
68. Taniguchi T., Matsui H., Fujita T., Takaoka C., Kashima N., Yoshimoto R., and Hamuro J. Structure and expression of a cloned cDNA for human interleukin-2. Nature 302 (1983) 305-310
69. Thèze J., Alzari P.M., and Bertoglio J. Interleukin 2 and its receptors: Recent advances and new immunological functions. Immunol. Today 17 (1996) 481-486
70. Van Parijs L., and Abbas A.K. Homeostasis and self-tolerance in the immune system: Turning lymphocytes off. Science 280 (1998) 243-248
71. Van Parijs L., Biuckians A., Ibragimov A., Alt F.W., Willerford D.M., and Abbas A.K. Functional responses and apoptosis of CD25 (IL-2R alpha)-deficient T cells expressing a transgenic antigen receptor. J. Immunol. 158 (1997) 3738-3745
72. Van Parijs L., Refaeli Y., Lord J.D., Nelson B.H., Abbas A.K., and Baltimore D. Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death. Immunity 11 (1999) 281-288
73. Vanham G., Kestens L., Vingerhoets J., Penne G., Colebunders R., Vandenbruaene M., Goeman J., Ceuppens J.L., Sugamura K., and Gigase P. The interleukin-2 receptor subunit expression and function on peripheral blood lymphocytes from HIV-infected and control persons. Clin. Immunol. Immunopathol. 71 (1994) 60-68
74. Walker E., Leemhuis T., and Roeder W. Murine B lymphoma cell lines release functionally active interleukin 2 after stimulation with Staphylococcus aureus. J. Immunol. 140 (1988) 859-865
75. Weiss L., Donkova-Petrini V., Caccavelli L., Balbo M., Carbonneil C., and Levy Y. Human immunodeficiency virus-driven expansion of CD4+CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients. Blood 104 (2004) 3249-3256
76. Willerford D.M., Chen J., Ferry J.A., Davidson L., Ma A., and Alt F.W. Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3 (1995) 521-530
77. Wrenshall L.E., and Platt J.L. Regulation of T cell homeostasis by heparan sulfate-bound IL-2. J. Immunol. 163 (1999) 3793-3800
78. Yang J.C., Sherry R.M., Steinberg S.M., Topalian S.L., Schwartzentruber D.J., Hwu P., Seipp C.A., Rogers-Freezer L., Morton K.E., White D.E., Liewehr D.J., Merino M.J., et al. Randomized study of high-dose and low-dose interleukin-2 in patients with metastatic renal cancer. J. Clin. Oncol. 21 (2003) 3127-3132
79. Zhang H., Chua K.S., Guimond M., Kapoor V., Brown M.V., Fleisher T.A., Long L.M., Bernstein D., Hill B.J., Douek D.C., Berzofsky J.A., Carter C.S., et al. Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells. Nat. Med. 11 (2005) 1238-1243
80. Zhou Y.J., Magnuson K.S., Cheng T.P., Gadina M., Frucht D.M., Galon J., Candotti F., Geahlen R.L., Changelian P.S., and O'Shea J.J. Hierarchy of protein tyrosine kinases in interleukin-2 (IL-2) signaling: Activation of syk depends on Jak3; however, neither Syk nor Lck is required for IL-2-mediated STAT activation. Mol. Cell. Biol. 20 (2000) 4371-4380